Shree Pacetronix [SHREEPAC] vs Dr Agarwal's Health [AGARWALEYE] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Shree Pacetronix Ltd. wins in 12 metrics, Dr Agarwal's Health Care Ltd wins in 6 metrics, with 0 ties. Shree Pacetronix Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shree Pacetronix Ltd. | Dr Agarwal's Health Care Ltd | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.75 | 109.80 | Shree Pacetronix Ltd. |
| Price-to-Book Ratio | 3.24 | 7.17 | Shree Pacetronix Ltd. |
| Debt-to-Equity Ratio | 32.04 | 48.68 | Shree Pacetronix Ltd. |
| PEG Ratio | -0.14 | 77.92 | Dr Agarwal's Health Care Ltd |
| EV/EBITDA | 12.06 | 30.74 | Shree Pacetronix Ltd. |
| Profit Margin (TTM) | 12.10% | 6.38% | Shree Pacetronix Ltd. |
| Operating Margin (TTM) | 6.16% | 14.22% | Dr Agarwal's Health Care Ltd |
| EBITDA Margin (TTM) | 6.16% | 14.22% | Dr Agarwal's Health Care Ltd |
| Return on Equity | 5.44% | 4.33% | Shree Pacetronix Ltd. |
| Return on Assets (TTM) | 3.25% | 2.27% | Shree Pacetronix Ltd. |
| Free Cash Flow (TTM) | $-72,464 | $394.30M | Dr Agarwal's Health Care Ltd |
| 1-Year Return | 74.51% | 43.01% | Shree Pacetronix Ltd. |
| Price-to-Sales Ratio (TTM) | 2.59 | 7.03 | Shree Pacetronix Ltd. |
| Enterprise Value | $547.67M | $144.88B | Dr Agarwal's Health Care Ltd |
| EV/Revenue Ratio | 2.67 | 7.33 | Shree Pacetronix Ltd. |
| Gross Profit Margin (TTM) | 69.97% | 62.87% | Shree Pacetronix Ltd. |
| Revenue per Share (TTM) | $57 | $63 | Dr Agarwal's Health Care Ltd |
| Earnings per Share (Diluted) | $6.84 | $3.99 | Shree Pacetronix Ltd. |
| Beta (Stock Volatility) | -0.98 | N/A | N/A |
Shree Pacetronix Ltd. vs Dr Agarwal's Health Care Ltd Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shree Pacetronix Ltd. | 7.97% | -11.71% | -1.29% | 14.62% | -42.94% | -28.10% |
| Dr Agarwal's Health Care Ltd | -2.58% | -0.64% | 5.30% | 6.33% | -8.21% | -4.74% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shree Pacetronix Ltd. | 74.51% | -4.56% | 1,372.60% | 770.95% | 276.72% | 1,482.22% |
| Dr Agarwal's Health Care Ltd | 43.01% | 20.41% | 20.41% | 20.41% | 20.41% | 20.41% |
Performance & Financial Health Analysis: Shree Pacetronix Ltd. vs Dr Agarwal's Health Care Ltd
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹532.08M | ₹138.86B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 4,031 | 98,862 |
| 90 Day Avg. Volume | 4,292 | 169,210 |
| Last Close | ₹140.90 | ₹464.25 |
| 52 Week Range | ₹66.10 - ₹283.15 | ₹332.50 - ₹568.00 |
| % from 52W High | -50.24% | -18.27% |
| All-Time High | ₹391.90 (Nov 06, 2023) | ₹568.00 (Oct 16, 2025) |
| % from All-Time High | -64.05% | -18.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.23% |
| Quarterly Earnings Growth | 0.20% | 0.51% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.06% |
| Operating Margin (TTM) | 0.06% | 0.14% |
| Return on Equity (TTM) | 0.05% | 0.04% |
| Debt to Equity (MRQ) | 32.04 | 48.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹43.78 | ₹61.13 |
| Cash per Share (MRQ) | ₹3.55 | ₹12.58 |
| Operating Cash Flow (TTM) | ₹-25,029 | ₹1.43B |
| Levered Free Cash Flow (TTM) | ₹7.50M | ₹834.60M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Shree Pacetronix Ltd. vs Dr Agarwal's Health Care Ltd
| Metric | SHREEPAC (Apr 26, 2026) | AGARWALEYE (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.75 | 109.80 |
| Forward P/E | N/A | 77.92 |
| PEG Ratio | -0.14 | 77.92 |
| Price to Sales (TTM) | 2.59 | 7.03 |
| Price to Book (MRQ) | 3.24 | 7.17 |
| Market Capitalization | ||
| Market Capitalization | ₹532.08M | ₹138.86B |
| Enterprise Value | ₹547.67M | ₹144.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.67 | 7.33 |
| Enterprise to EBITDA | 12.06 | 30.74 |
| Risk & Other Metrics | ||
| Beta | -0.98 | N/A |
| Book Value per Share (MRQ) | ₹43.78 | ₹61.13 |
Financial Statements Comparison: Shree Pacetronix Ltd. vs Dr Agarwal's Health Care Ltd
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SHREEPAC (2025) | AGARWALEYE (2025) |
|---|---|---|
| Revenue/Sales | 168.03M | 17.05B |
| Cost of Goods Sold | 65.81M | 9.36B |
| COGS % of Revenue | 39.2% | 54.9% |
| Gross Profit | 102.22M | 7.69B |
| Gross Margin | 60.8% | 45.1% |
| Research & Development | 4.42M | N/A |
| Operating Income (EBIT) | 15.31M | 2.49B |
| Operating Margin | 9.1% | 14.6% |
| EBITDA | 24.33M | 4.91B |
| EBITDA Margin | 14.5% | 28.8% |
| Pre-Tax Income | 10.43M | 1.60B |
| Pre-Tax Income % of Revenue | 6.2% | 9.4% |
| Income Tax | 2.93M | 495.10M |
| Income Tax % of Revenue | 1.7% | 2.9% |
| Net Income (Profit) | 7.50M | 1.10B |
| Profit Margin | 4.5% | 6.5% |
Balance Sheet & Liquidity Metrics
| Metric | SHREEPAC (2025) | AGARWALEYE (2025) |
|---|---|---|
| Cash & Equivalents | 1.78M | 1.04B |
| Total Current Assets | 171.89M | 7.94B |
| Total Current Assets % of Revenue | 102.3% | 46.6% |
| Total Current Liabilities | 88.66M | 4.78B |
| Total Current Liabilities % of Revenue | 52.8% | 28.0% |
| Long-Term Debt | 3.61M | 8.08B |
| Long-Term Debt % of Revenue | 2.1% | 47.4% |
| Total Shareholders Equity | 137.82M | 19.27B |
| Retained Earnings | 94.54M | -1.85B |
| Retained Earnings % of Revenue | 56.3% | -10.9% |
| Property, Plant & Equipment | 245,392 | 6.60B |
Cash Flow Statement Comparison
| Metric | SHREEPAC (2025) | AGARWALEYE (2025) |
|---|---|---|
| Operating Cash Flow | -25,029 | 1.43B |
| Operating Cash Flow % of Revenue | 0.0% | 8.4% |
| Capital Expenditures | -71,674 | 5.30M |
| Free Cash Flow | -72,464 | 394.30M |
| FCF Margin | 0.0% | 2.3% |
| Debt Repayment | -1.84M | -2.03B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 3.75M | 316.96M |
| Float Shares | 918,023 | 60.08M |
| % Held by Insiders | 66.74% | 75.49% |
| % Held by Institutions | 0.00% | 16.46% |
| % Held by Public | 33.26% | 8.05% |
Dividend Analysis & Yield Comparison: Shree Pacetronix Ltd. vs Dr Agarwal's Health Care Ltd
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |